1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4. Voice of Customer
5.
Global Intravenous Iron Drugs Market Outlook
5.1.
Market Size & Forecast
5.1.1. By Value &
Volume
5.2.
Market Share & Forecast
5.2.1. By Application
(Intestinal malabsorption syndromes, Inflammatory diseases,
Gastrectomy/bariatric surgery, Anemia, Osier-Weber-Rendu disease, Angiodysplasia,
Pregnancy, Others)
5.2.2. By Product (Iron
dextran, Ferric gluconate, Iron sucrose, Ferric carboxymaltos, Iron
isomaltoside 1000, Ferumoxytol)
5.2.3. By End-User
(Hospitals & Clinics, Ambugalotry Care, Homecare, Others)
5.2.4. By Company (2022)
5.2.5. By Region
5.3. Market Map
6. Clinical Trial
Analysis
6.1. Ongoing Clinical
Trials
6.2. Completed Clinical
Trials
6.3. Terminated Clinical
Trials
6.4. Breakdown of
Pipeline, By Development Phase
6.5. Breakdown of
Pipeline, By Status
6.6. Breakdown of
Pipeline, By Study Type
6.7. Breakdown of
Pipeline, By Country
6.8. Clinical Trials Heat
Map
7.
Asia-Pacific Intravenous Iron Drugs Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value &
Volume
7.2.
Market Share & Forecast
7.2.1. By Application
7.2.2. By Product
7.2.3. By End-User
7.2.4. By Country
7.3.
Asia-Pacific: Country Analysis
7.3.1. China Intravenous
Iron Drugs Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Application
7.3.1.2.2.
By Product
7.3.1.2.3.
By End-User
7.3.2. India Intravenous
Iron Drugs Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Application
7.3.2.2.2.
By Product
7.3.2.2.3.
By End-User
7.3.3. Japan Intravenous
Iron Drugs Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Application
7.3.3.2.2.
By Product
7.3.3.2.3.
By End-User
7.3.4. South Korea
Intravenous Iron Drugs Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Application
7.3.4.2.2.
By Product
7.3.4.2.3.
By End-User
7.3.5. Australia
Intravenous Iron Drugs Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Application
7.3.5.2.2.
By Product
7.3.5.2.3.
By End-User
8.
Europe Intravenous Iron Drugs Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value &
Volume
8.2.
Market Share & Forecast
8.2.1. By Application
8.2.2. By Product
8.2.3. By End-User
8.2.4. By Country
8.3.
Europe: Country Analysis
8.3.1. France Intravenous
Iron Drugs Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Application
8.3.1.2.2.
By Product
8.3.1.2.3.
By End-User
8.3.2. Germany Intravenous
Iron Drugs Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Application
8.3.2.2.2.
By Product
8.3.2.2.3.
By End-User
8.3.3. United Kingdom
Intravenous Iron Drugs Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Application
8.3.3.2.2.
By Product
8.3.3.2.3.
By End-User
8.3.4. Italy Intravenous
Iron Drugs Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Application
8.3.4.2.2.
By Product
8.3.4.2.3.
By End-User
9.
North America Intravenous Iron Drugs Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value &
Volume
9.2.
Market Share & Forecast
9.2.1. By Application
9.2.2. By Product
9.2.3. By End-User
9.2.4. By Country
9.3.
North America: Country Analysis
9.3.1. United States
Intravenous Iron Drugs Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Application
9.3.1.2.2.
By Product
9.3.1.2.3.
By End-User
9.3.2. Mexico Intravenous
Iron Drugs Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Application
9.3.2.2.2.
By Product
9.3.2.2.3.
By End-User
9.3.3. Canada Intravenous
Iron Drugs Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Application
9.3.3.2.2.
By Product
9.3.3.2.3.
By End-User
10.
South America Intravenous Iron Drugs Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value &
Volume
10.2.
Market Share & Forecast
10.2.1. By Application
10.2.2. By Product
10.2.3. By End-User
10.2.4. By Country
10.3.
South America: Country Analysis
10.3.1. Brazil Intravenous
Iron Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Application
10.3.1.2.2.
By Product
10.3.1.2.3.
By End-User
10.3.2. Argentina
Intravenous Iron Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Application
10.3.2.2.2.
By Product
10.3.2.2.3.
By End-User
10.3.3. Colombia Intravenous
Iron Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Application
10.3.3.2.2.
By Product
10.3.3.2.3.
By End-User
11.
Middle East and Africa Intravenous Iron Drugs
Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value &
Volume
11.2.
Market Share & Forecast
11.2.1. By Application
11.2.2. By Product
11.2.3. By End-User
11.2.4. By Country
11.3.
MEA: Country Analysis
11.3.1. South Africa
Intravenous Iron Drugs Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1.
By Application
11.3.1.2.2.
By Product
11.3.1.2.3.
By End-User
11.3.2. Saudi Arabia
Intravenous Iron Drugs Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1.
By Application
11.3.2.2.2.
By Product
11.3.2.2.3.
By End-User
11.3.3. UAE Intravenous Iron
Drugs Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1.
By Application
11.3.3.2.2.
By Product
11.3.3.2.3.
By End-User
12.
Market Dynamics
12.1.
Drivers
12.2.
Challenges
13.
Market Trends & Developments
14.
Competitive Landscape
14.1.
Competition Outlook
14.2.
Players Profiled (Leading Companies)
14.2.1. AMAG pharmaceuticals,
Inc.
14.2.2. Vifor Pharma
Management Ltd.
14.2.3. Daiichi Sankyo
Company, Limited
14.2.4. Rockwell Medical
Inc.
14.2.5. Allergan PLC
14.2.6. Pfizer Inc
14.2.7. Nippon Shinyaku Co.
14.2.8. Novartis
International AG
14.2.9. Takeda
Pharmaceutical Company Limited
14.2.10.
Bausch Health Companies Inc.
15. Strategic Recommendations